Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Chinese Classics recitation training for people with subjective memory concerns

Official title: The Effect of Memory Training by Chinese Classics Recitation on Individuals With Subjective Cognitive Decline

Run by China Medical University Hospital · NCT07463391 · Data updated 2026-11-12

A 6-month program of Chinese Classics recitation is being tested to see if it helps people aged 60+ who notice memory problems but don’t have measurable impairment.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment60 (estimated)
SponsorChina Medical University Hospital
Academic / other
Locations1 site (Taichung)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedJuly 31, 2029
Study endsDecember 31, 2032
Registry record updatedOctober 22, 2026
Trial IDNCT07463391 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 60 or older with self-reported memory concerns but no objective cognitive impairment or dementia.

Probably not a fit

Individuals with objective cognitive impairment, MCI, or dementia, or with significant psychiatric or medical conditions that could explain memory problems, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, assessor-blinded trial will enroll 60 adults 60 years or older with subjective cognitive decline and randomly assign them to the recitation training or a non-active control for six months. Participants will undergo neuropsychological testing, plus multimodal brain and biological assessments (fMRI, EEG, blood biomarkers, gut microbiota, and fecal metabolomics) at baseline, after the intervention, and during annual follow-ups. The goal is to understand potential brain and biological changes associated with this culturally tailored memory-training approach. Results will help determine whether this training can slow or alter early cognitive concerns and what biomarkers may reflect any effects.

Why it matters

Potential benefit: If successful, participants may experience improvements in memory-related performance and associated brain function.

How similar studies have gone: Previous studies in cognitive training show potential, but responses vary; this approach adds a culturally tailored intervention with multimodal assessments to explore novelty and effectiveness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 60 years old
* At least two "yes" responses to the following questions are required:

  1. Forgetting where things are placed?
  2. Unable to recall the names of good friends?
  3. Unable to follow and recall conversation?
  4. Subjective memory problems?
  5. Consider own memory to be worse than others of a similar age?

Exclusion Criteria:

* Objective cognitive impairment defined as ≥ 1.5 standard deviations below standardized cognitive testing (e.g., MMSE)
* Diagnosis of MCI
* Clinical Dementia Rating (CDR) ≥ 0.5
* Diagnosis of major depressive disorder
* Beck Anxiety Inventory score ≥ 16
* Other medical or neurological conditions that could explain cognitive decline (e.g., vascular dementia, traumatic brain injury)
* Claustrophobia
* Contraindications of MRI (e.g., non-MRI-compatible cardiac pacemaker or devices implanted within the past three months)

Where it's running

  • China Medical University Hospital
    Taichung, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.